查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1468259

2024-2032 年腎上腺素自動注射器市場報告（按劑量、應用、最終用戶和地區）

Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group自動注射器市場規模達24億美元。過敏人群數量不斷增加、自我給藥需求不斷增加以及智慧腎上腺素自動注射器的推出是推動市場發展的一些關鍵因素。

腎上腺素自動注射器是一種醫療設備，用於輕鬆注射單劑量腎上腺素，用於治療蜇傷、蟲咬或藥物引起的嚴重過敏反應。它的設計目的是將藥物輸送到個體的大腿肌肉中，並透過收縮血管和擴張氣道來發揮作用，以盡量減少過敏反應的症狀。它體積小，易於攜帶，可由個人或醫療保健專業人員管理。目前，領先的製造商正在推出多劑量、劑量可調的腎上腺素自動注射器，使用戶能夠根據過敏反應的嚴重程度調整劑量，提高治療效果。它們還結合了音訊和視覺說明，使個人在緊急情況下更容易使用它們。

腎上腺素自動注射器市場趨勢：

患有過敏和過敏反應的人數不斷增加，以及對自我給藥藥物的需求不斷成長，是推動全球腎上腺素自動注射器需求的主要因素之一。此外，關節炎、氣喘、癌症和慢性阻塞性肺病（COPD）的盛行率飆升以及人口老化的加劇（更容易出現過敏反應）正在對市場產生積極影響。此外，大眾食物過敏發生率的增加也促進了市場的成長。除此之外，許多國家的管理機構正在採取舉措，促進在學校和其他公共場所使用腎上腺素自動注射器。再加上人們對腎上腺素自動注射器的認知不斷提高，正在促進市場的成長。此外，主要參與者正在推出智慧腎上腺素自動注射器，這些注射器整合了藍牙連接、感測器和機器學習等先進技術，使其更加方便、方便用戶使用和有效。領先的參與者還推出了可以連接到智慧型手機或其他設備的行動應用程式，允許遠端監控、追蹤使用情況和有效期，並確保患者不超過建議的劑量。這些進步還可以幫助預測過敏反應的可能性並提供個人化的治療建議。再加上將自動體外心臟去顫器 (AED) 納入腎上腺素自動注射器以提供全面的緊急應變系統，正在為市場創造積極的前景。

本報告回答的關鍵問題：

  • 迄今為止，全球腎上腺素自動注射器市場表現如何，未來幾年將如何表現？
  • 全球腎上腺素自動注射器市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球腎上腺素自動注射器市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的腎上腺素自動注射器市場？
  • 根據劑量，市場細分是多少？
  • 腎上腺素自動注射器市場上哪種劑量最具吸引力？
  • 基於應用程式的市場區隔是什麼？
  • 腎上腺素自動注射器市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 腎上腺素自動注射器市場中哪一個是最具吸引力的最終用戶？
  • 全球腎上腺素自動注射器市場的競爭結構如何？
  • 全球腎上腺素自動注射器市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腎上腺素自動注射器市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按劑量

  • 0.15mg 腎上腺素自動注射器
    • 市場走向
    • 市場預測
  • 0.3mg 腎上腺素自動注射器
    • 市場走向
    • 市場預測
  • 0.5mg 腎上腺素自動注射器
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 6歲以下
    • 市場走向
    • 市場預測
  • 6至12歲
    • 市場走向
    • 市場預測
  • 超過12年
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Adamis Pharmaceuticals Corporation
    • Amneal Pharmaceuticals Inc.
    • Antares Pharma Inc
    • Bausch Health
    • Kaleo Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112024A7369

The global epinephrine autoinjector market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.21% during 2024-2032. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency.

Epinephrine Autoinjector Market Trends:

The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on dosage, application, and end user.

Dosage Insights:

0.15mg Epinephrine Autoinjector

0.3mg Epinephrine Autoinjector

0.5mg Epinephrine Autoinjector

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.

Application Insights:

Under 6 Years

6 to 12 Years

Over 12 Years

A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.

End User Insights:

Hospitals

Clinics

Others

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
  • What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
  • What are the key regional markets?
  • Which countries represent the most attractive epinephrine autoinjector markets?
  • What is the breakup of the market based on the dosage?
  • Which is the most attractive dosage in the epinephrine autoinjector market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the epinephrine autoinjector market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the epinephrine autoinjector market?
  • What is the competitive structure of the global epinephrine autoinjector market?
  • Who are the key players/companies in the global epinephrine autoinjector market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epinephrine Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dosage

  • 6.1 0.15mg Epinephrine Autoinjector
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 0.3mg Epinephrine Autoinjector
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 0.5mg Epinephrine Autoinjector
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Under 6 Years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 6 to 12 Years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Over 12 Years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adamis Pharmaceuticals Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Amneal Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Antares Pharma Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Bausch Health
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Kaleo Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Teva Pharmaceutical Industries Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Viatris Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Epinephrine Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Epinephrine Autoinjector Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Epinephrine Autoinjector Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Epinephrine Autoinjector Market: Breakup by Dosage (in %), 2023
  • Figure 5: Global: Epinephrine Autoinjector Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Epinephrine Autoinjector Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Epinephrine Autoinjector Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Epinephrine Autoinjector (Under 6 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Epinephrine Autoinjector (Under 6 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Epinephrine Autoinjector (6 to 12 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Epinephrine Autoinjector (6 to 12 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Epinephrine Autoinjector (Over 12 Years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Epinephrine Autoinjector (Over 12 Years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Epinephrine Autoinjector (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Epinephrine Autoinjector (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Epinephrine Autoinjector (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Epinephrine Autoinjector (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Epinephrine Autoinjector (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Epinephrine Autoinjector (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Epinephrine Autoinjector Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Epinephrine Autoinjector Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Epinephrine Autoinjector Industry: Value Chain Analysis
  • Figure 77: Global: Epinephrine Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epinephrine Autoinjector Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Epinephrine Autoinjector Market Forecast: Breakup by Dosage (in Million US$), 2024-2032
  • Table 3: Global: Epinephrine Autoinjector Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Epinephrine Autoinjector Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Epinephrine Autoinjector Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Epinephrine Autoinjector Market: Competitive Structure
  • Table 7: Global: Epinephrine Autoinjector Market: Key Players